GGrantIndex
Sort

64,565 grants matching drug discovery

Xavier RCMI Renewal Application-Administrative Core

$560,378
Guangdi Wang · Xavier University Of Louisiana · U54 · FY2021 · MD

Xavier RCMI Renewal Application-Overall

$560,378
Guangdi Wang · Xavier University Of Louisiana · U54 · FY2021 · MD

Signature-Directed Combination Mitigator Therapy Based on GS-Nitroxides

$560,363
Joel S Greenberger · University Of Pittsburgh At Pittsburgh · U19 · FY2018 · AI

Molecular basis of complement anaphylatoxin receptor activation, regulation, selectivity and signaling bias

$560,354
Cornelius Gati · University Of Southern California · R01 · FY2025 · AI

MECHANISM AND REGULATION OF RECEPTOR-G PROTEIN SIGNALING

$560,317
Kendall Jay Blumer · Washington University · R01 · FY2015 · GM

MECHANISM AND REGULATION OF RECEPTOR-G PROTEIN SIGNALING

$560,317
Kendall Jay Blumer · Washington University · R01 · FY2016 · GM

MECHANISM AND REGULATION OF RECEPTOR-G PROTEIN SIGNALING

$560,317
Kendall Jay Blumer · Washington University · R01 · FY2014 · GM

MECHANISM AND REGULATION OF RECEPTOR-G PROTEIN SIGNALING

$560,317
Kendall Jay Blumer · Washington University · R01 · FY2017 · GM

Immunity to Liver-stage malaria

$560,303
John T. Harty · University Of Iowa · R01 · FY2022 · AI

Immunity to Liver-stage malaria

$560,303
John T. Harty · University Of Iowa · R01 · FY2024 · AI

Immunity to Liver-stage malaria

$560,303
John T. Harty · University Of Iowa · R01 · FY2023 · AI

Deciphering the interplay between H3K36 and DNA methylation in renal cancer

$560,270
Keith D Robertson · Mayo Clinic Rochester · R01 · FY2019 · CA

Targeting Cyclic Dinucleotide Signaling Pathways to Interrupt the Nature Cycle of Borrelia burgdorferi

$560,225
Xiaofeng Frank Yang · Indiana University Indianapolis · R01 · FY2024 · AI

Targeting Cyclic Dinucleotide Signaling Pathways to Interrupt the Nature Cycle of Borrelia burgdorferi

$560,225
Xiaofeng Frank Yang · Indiana University Indianapolis · R01 · FY2023 · AI

Mapping Protein Interaction Networks Essential for Gonococcal Pathogenesis

$560,203
Andrew Emili · Oregon Health & Science University · R01 · FY2025 · AI

Omic analyses for stratifying Alzheimer's subtypes and identifying novel drug targets

$560,128
Chi-Hua Chen · University Of California, San Diego · R56 · FY2018 · AG

Flecainide for Catecholaminergic Polymorphic Ventricular Tachycardia

$560,115
Prince Joseph Kannankeril · Vanderbilt University · R01 · FY2011 · HL

Chemical instruments-aware distributed blockchain based open AI platform to accelerate drug discovery

$560,113
Gaurav Chopra · Purdue University · U18 · FY2023 · TR

Launching HBV with RNA to assess antiviral resistance and explore fundamental aspects of virus-host biology

$560,079
Charles M. Rice · Rockefeller University · R01 · FY2020 · AI

Evolutionary potential of HIV-1 capsid: mechanisms and consequences

$560,076
Masahiro Yamashita · Columbia University Health Sciences · R01 · FY2024 · AI

Discovery of small molecule inhibitors for protein N-terminal acetyltransferase D

$560,032
Rong Huang · Purdue University · R01 · FY2023 · CA

Basic Dopamine Transporter Mechanisms Of Cocaine

$560,011
Jonathan L Katz · National Institute On Drug Abuse · ZIA · FY2009 · DA

CAREER: Probing Nucleic Acid Structure through Gas-Phase Ion-Electron Reactions

$560,000
Kristina Hakansson · Regents Of The University Of Michigan - Ann Arbor · · FY2006 · MPS

DCTD Tumor Hypoxia

$560,000
Larry Arthur · Science Applications International Corp · N01 · FY2009 · CA

NCI Experimental Therapeutics-Clinical Trials Network with Phase 1 Emphasis

$559,998
Paul Haluska · Mayo Clinic Rochester · UM1 · FY2014 · CA